George Silver, DPM
Foot Surgery · Orange, TXNPI 1366405581
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,543 of the $8,811 with a category attached, or 62.9%. 18 manufacturers reported payments, led by Smith+Nephew at 40.8% of the total. Reporting peaked in 2019 at $2,471 and has fallen 84.5% since, to $383 in 2025.
Across 213 payments — averaging $41.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$4K
- Medical Device Business Services, Inc.$1K
- Arthrosurface Incorporated$1K
- Paragon 28, Inc.$1K
- Kerecis Limited$340
- Johnson & Johnson$336
- plus $1K from 12 others
What the payments were for
- Travel & lodging$3,26937%
- Food & beverage$5,54363%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 153 | $3,599 |
| Medical Device Business Services, Inc. | 6 | $1,326 |
| Arthrosurface Incorporated | 11 | $1,155 |
| Paragon 28, Inc. | 4 | $1,004 |
| Kerecis Limited | 6 | $340 |
| Johnson & Johnson | 5 | $336 |
| Melinta Therapeutics, LLC | 11 | $233 |
| Crossroads Extremity Systems, LLC | 1 | $217 |
| Osiris Therapeutics Inc. | 5 | $165 |
| Alafair Biosciences, Inc. | 1 | $149 |
| Averitas Pharma Inc. | 1 | $103 |
| Treace Medical Concepts, Inc. | 2 | $51 |
| AbbVie | 2 | $37 |
| Ossio Inc | 1 | $22 |
| Organogenesis Inc. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Medinc Of Texas | 1 | $18 |
| Nevro Corp. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HemiCAP MTP Resurfacing$902
- Oasis$812
- VERSAJET II$689
- Renasys$689
- Grafix$689
- PICO$689
- Kerecis SurgiClose$457
- MOTOBAND$402
- Medical Implant$217
- VersaWrap$149
- Santyl$123
- REGRANEX$123
- Kerecis GraftGuide$114
- Qutenza$103
How this compares
$8,811 in reported general payments places this provider in the 80th percentile of 71 foot surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium ErDiclofenac Sodium | 71 | $2,416 |
| Terbinafine Hcl | 30 | $807 |
| Mupirocin | 62 | $556 |
| Pregabalin | 14 | $244 |
| Gabapentin | 17 | $183 |
| Tramadol Hcl | 13 | $164 |
| Diclofenac Sodium | 14 | $149 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $142 |
| Clindamycin Hcl | 12 | $137 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $115 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 27 | $83 |
| Cephalexin | 16 | $74 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Orange
- Marque AllenSan Antonio$204K
- James JacobsKaty$81K
- Lawrence LaverySan Antonio$59K
- Robert GraserBoerne$54K
- Richard KehSan Antonio$17K
- Chad ClauseWebster$17K
- Seth AshrafSan Antonio$17K
- Kris FordSan Antonio$15K
- Fernando CruzCorsicana$12K
- Richard GalperinDallas$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.